
@AffinityWater at least one of the leaks is still happily watering Totteridge Lane towards Longland Drive

Respiratory Dr with interest in asthma and airways immunology, personalised medicine and effects of the environment. Also coffee, comedies and music.

@AffinityWater at least one of the leaks is still happily watering Totteridge Lane towards Longland Drive

ERJ Open Research: Young adults with severe asthma experience disproportionately poor outcomes despite specialist care, highlighting the need for age-appropriate personalised management bit.ly/3KiSIaS

#newpublication Alert ‼️ EGPA, benralizumab reduced airway autoimmune responses (spANCA and IL-17A) and eosinophilic inflammation, while mepolizumab was linked to persistent or increased autoimmune activity bit.ly/4hJJIYv check out the mechanistic substudy of #Mandara Trial #MukherjeeLab Shout out to PhD student Nadia Suray Tan for the crucial work @machealthsci @ResearchStJoes @ERSpublications

This week's question was written by Prof Paul Pfeffer, who is an Asthma specialist at Bart's Hospital. Answers to come Friday!

New respiratory education account Sharing Respiratory SCE-style questions, exam tips, and regular updates on UK courses, key papers, podcasts and exam news. Follow along and learn together. #MedTwitter #Mededucation @LancetRespirMed @BTOGORG @BTSrespiratory

ERJOR: Severe asthma biologics are effective in a broad range of patients, including those not meeting the inclusion/exclusion criteria for phase 3 RCTs, although noninferiority could not be shown for those RCT-ineligible by poor medication adherence bit.ly/40ZL8a8

Indoor and outdoor air pollution come from many sources and can worsen asthma control @DoctorPfeffer @dr_abi_w bit.ly/ERSM108

And to provide patient-friendly education on why we might advise changes to inhaled therapy. @NHSBartsHealth @NELHCP youtube.com/watch?v=DvJ1HdzD…

Important to understand the health beliefs of patients towards changes to their asthma medication, including in emergency settings @ImogenSkene emj.bmj.com/content/early/20… bmjopenrespres.bmj.com/conte…

Clear association between frequent SABA use and acute cardiovascular events in both patients with asthma/COPD and those without. Salbutamol is not a benign medication that can be taken excessively without any risks. dovepress.com/association-of…

Great to see our new paper out showing the cardiovascular dangers from high SABA blue reliever use. And our recent research on implementing SABA-free management. @QMULBartsTheLon @opri_sg linkedin.com/feed/update/urn…

A great infographic @asthma management. @BTSrespiratory @asthmalunguk
This articles summarises recommendations on asthma diagnosis, monitoring, and chronic management. This #BMJInfographic outlines new management pathways for people aged 5 years and older bmj.com/content/390/bmj.r116…

Is an Emergency Department presentation at opportunity to tackle SABA overuse and improve asthma control? Our new paper explores patient beliefs, and attitudes to inhaler changes @DoctorPfeff bmjopenrespres.bmj.com/conte… #Asthma #EmergencyMedicine

We've developed a short video for people with asthma who may be offered a new type of inhaler therapy called MART or AIR. 🎥 Watch the video here: youtube.com/watch?v=DvJ1HdzD… ✅ Right medication ✅ Right way ✅ Right support #asthma @DoctorPfeff

The BTS/NICE/SIGN asthma guideline @BTSrespiratory Read the editorial I’ve written- thorax.bmj.com/content/early…
BTS/NICE/SIGN joint guideline on asthma: diagnosis, monitoring and chronic asthma management (November 2024) - summary of recommendations thorax.bmj.com/content/early…

NIHR funded research has developed a mobile phone app to support people recovering from long Covid at home 📱 Read the #MakingaDifference story ➡️ nihr.ac.uk/story/living-covi…